0001209191-22-010403.txt : 20220216
0001209191-22-010403.hdr.sgml : 20220216
20220216201043
ACCESSION NUMBER: 0001209191-22-010403
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220209
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Seline E.
CENTRAL INDEX KEY: 0001769866
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 22645298
MAIL ADDRESS:
STREET 1: C/O REZOLUTE, INC.
STREET 2: 1450 INFINITE DRIVE
CITY: LOUISVILLE
STATE: CO
ZIP: 80027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-871-0761
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-09
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001769866
Miller Seline E.
C/O CATALYST BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 710
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP Finance; Interim CFO & PAO
Common Stock
2022-02-09
5
P
0
E
3250
0.46
A
3250
D
Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022.
/s/ Seline Miller
2022-02-15